Anti-Beta-2 Glycoprotein I IgG (anti-beta2-GPI IgG)
Autoantibodies targeting the cryptic Domain I epitope of circulating beta-2 glycoprotein I (apolipoprotein H).
Standard vs. Optimal Reference RangesSGU
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<20.0 SGU
General reference distribution across unselected commercial populations.
<10.0 SGU (negative)
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Cross-links beta-2-GPI on platelet and trophoblast surfaces, directly triggering thrombosis and placental infarctions.
Differential Diagnosis
Elevated Levels (anti-beta2-GPI IgG High)
- •Primary or secondary Antiphospholipid Syndrome (high thrombotic risk)
- •Recurrent first-trimester pregnancy loss
Low Levels (anti-beta2-GPI IgG Low)
- •Negative thrombophilic serology
- •Normal coagulation homeostasis
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for anti-beta2-GPI IgG
- Targeted organ system imaging or functional dynamic testing related to antiphospholipid thrombophilia
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Anti-Beta-2 Glycoprotein I IgG - The New England Journal of Medicine (2021). PMID: 33990124
- [2]anti-beta2-GPI IgG Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Anti-Beta-2 Glycoprotein I IgG (anti-beta2-GPI IgG) into overall healthspan optimization.